Telix Pharmaceuticals Shares Given Aggressive Price Target, as New Bull Emerges - The Bull

Telix Pharmaceuticals shares (ASX:TLX) have gained a new bull on Wall Street, giving beleaguered holders something to rally to behind, after a 50% drawdown over the past 12 months. JPMorgan has initiated coverage of TLX with an Overweight rating and A$23.60 price target, marking a significant vote of confidence in the company as it navigates